| Catalog Number |
1000100 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hematoma (1884); Cardiogenic Shock (2262)
|
| Date of Event |
03/23/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by abiomed inc, or its employees that the report constitutes an admission that the product, abiomed inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
Clinical narrative: a 66-year-old male with a history of cardiomyopathy presented in a pre support clinical state consistent with scai shock stage e.The patient was supported with an impella 5.5 device (sn (b)(6)) implanted via a right axillary/subclavian surgical arterial access on (b)(6) 2026 at 01:44 am.Following the removal of a previously placed intra aortic balloon pump (iabp), while the impella 5.5 remained in place and functioning, the patient developed significant vasodilation and hemorrhagic shock.There was clinical concern for a right sided retroperitoneal hematoma at the prior iabp access site.The patient became severely hemodynamically unstable with serum lactate levels reported as high as 10 mmol/l.Vascular surgery was consulted and continued to follow the patient; however, no surgical intervention was planned at the time of reporting due to clinical improvement.The reported event of hemorrhagic and vasodilatory shock occurred following iabp removal with suspected access site bleeding and was managed medically with improvement noted.There is no evidence at this time to suggest device malfunction, performance issue, or use error associated with the impella 5.5 system.The event appears related to patient underlying critical condition, scai shock stage e and procedural/access site complications rather than the device.The patient remains on impella support with survival outcome and explant status pending.
|
| |
|
Additional Manufacturer Narrative
|
|
Ppae (hematoma): the root cause of the injury was not determined due to insufficient clinical details.Additional information has been provided in h6 (component code, investigation findings, type of investigation, and investigation conclusions).
|
| |
|
Additional Manufacturer Narrative
|
|
D6b: explantation day, month and year.
|
| |
|
Search Alerts/Recalls
|